News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
57,189 Results
Type
Article (5084)
Company Profile (17)
Press Release (52086)
Multimedia
Podcasts (1)
Webinars (4)
Section
Business (17255)
Career Advice (263)
Deals (2686)
Drug Delivery (12)
Drug Development (3109)
Employer Resources (23)
FDA (1147)
Job Trends (1736)
News (24547)
Policy (2220)
Tag
Academia (566)
Allergies (4)
Alliances (5805)
ALS (7)
Alzheimer's disease (137)
Antibody-drug conjugate (ADC) (25)
Approvals (1162)
Artificial intelligence (126)
Autoimmune disease (13)
Automation (22)
Bankruptcy (24)
Best Places to Work (1216)
BIOSECURE Act (1)
Biosimilars (26)
Biotechnology (8)
Bladder cancer (3)
Brain cancer (6)
Breast cancer (46)
Cancer (339)
Cardiovascular disease (29)
Career advice (234)
Career pathing (12)
CAR-T (15)
CDC (2)
Cell therapy (50)
Cervical cancer (11)
Clinical research (2115)
Collaboration (232)
Compensation (14)
Complete response letters (1)
COVID-19 (533)
CRISPR (13)
C-suite (65)
Cystic fibrosis (9)
Data (336)
Denatured (1)
Depression (6)
Diabetes (17)
Diagnostics (1838)
Digital health (6)
Diversity (1)
Diversity, equity & inclusion (3)
Drug discovery (48)
Drug pricing (9)
Drug shortages (2)
Duchenne muscular dystrophy (4)
Earnings (4722)
Editorial (6)
Employer branding (2)
Employer resources (21)
Events (6074)
Executive appointments (90)
FDA (1325)
Friedreich's ataxia (2)
Frontotemporal dementia (3)
Funding (191)
Gene editing (22)
Generative AI (11)
Gene therapy (35)
GLP-1 (67)
Government (500)
Grass and pollen (1)
Guidances (25)
Healthcare (1553)
HIV (6)
Huntington's disease (2)
IgA nephropathy (2)
Immunology and inflammation (14)
Immuno-oncology (4)
Indications (3)
Infectious disease (572)
Inflammatory bowel disease (15)
Influenza (35)
Intellectual property (12)
Interviews (34)
IPO (919)
IRA (5)
Job creations (516)
Job search strategy (198)
JPM (11)
Labor market (20)
Layoffs (49)
Leadership (15)
Legal (387)
Liver cancer (2)
Longevity (3)
Lung cancer (33)
Lymphoma (26)
Machine learning (15)
Management (5)
Manufacturing (109)
MASH (2)
Medical device (1021)
Medtech (1026)
Mergers & acquisitions (1863)
Metabolic disorders (49)
Multiple sclerosis (6)
Neurodegenerative disease (21)
Neuropsychiatric disorders (3)
Neuroscience (224)
Neurotech (1)
NextGen: Class of 2026 (718)
Non-profit (554)
Now hiring (19)
Obesity (29)
Opinion (57)
Ovarian cancer (10)
Pain (8)
Pancreatic cancer (12)
Parkinson's disease (26)
Partnered (9)
Patents (22)
Patient recruitment (20)
Peanut (4)
People (4940)
Pharmaceutical (2)
Phase 1 (755)
Phase 2 (951)
Phase 3 (730)
Pipeline (460)
Policy (14)
Postmarket research (98)
Preclinical (526)
Press Release (18)
Prostate cancer (22)
Psychedelics (5)
Radiopharmaceuticals (13)
Rare diseases (39)
Real estate (1448)
Recruiting (13)
Regulatory (1612)
Reports (11)
Research institute (540)
Resumes & cover letters (31)
Rett syndrome (3)
RNA editing (1)
RSV (8)
Schizophrenia (7)
Series A (35)
Series B (20)
Service/supplier (2)
Sickle cell disease (2)
Special edition (3)
Spinal muscular atrophy (5)
Sponsored (8)
Startups (507)
Stomach cancer (1)
Supply chain (11)
Tariffs (4)
Vaccines (61)
Venture capital (19)
Weight loss (18)
Women's health (10)
Worklife (5)
Date
Today (5)
Last 7 days (48)
Last 30 days (170)
Last 365 days (2259)
2026 (229)
2025 (2276)
2024 (2835)
2023 (3374)
2022 (4910)
2021 (5062)
2020 (5680)
2019 (4238)
2018 (3037)
2017 (2963)
2016 (3167)
2015 (3192)
2014 (2226)
2013 (1958)
2012 (2099)
2011 (2209)
2010 (1633)
Location
Africa (110)
Alabama (11)
Alaska (1)
Arizona (28)
Arkansas (1)
Asia (3205)
Australia (512)
California (803)
Canada (233)
China (77)
Colorado (38)
Connecticut (94)
Delaware (15)
Europe (6373)
Florida (61)
Georgia (27)
Idaho (5)
Illinois (58)
India (13)
Indiana (62)
Iowa (7)
Japan (25)
Kansas (6)
Kentucky (3)
Louisiana (3)
Maine (6)
Maryland (89)
Massachusetts (610)
Michigan (87)
Minnesota (44)
Mississippi (1)
Missouri (29)
Montana (4)
Nebraska (5)
Nevada (10)
New Hampshire (9)
New Jersey (176)
New Mexico (11)
New York (262)
North Carolina (123)
North Dakota (3)
Northern California (392)
Ohio (62)
Oklahoma (3)
Oregon (8)
Pennsylvania (170)
Rhode Island (3)
South America (190)
South Carolina (8)
Southern California (280)
Tennessee (40)
Texas (133)
United States (3124)
Utah (53)
Virginia (19)
Washington D.C. (4)
Washington State (77)
West Virginia (2)
Wisconsin (21)
57,189 Results for "pax labs".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Repligen Appoints Maggie A. Pax to Board of Directors
Repligen Corporation announced the appointment to its Board of Directors of life sciences industry executive Maggie A. Pax.
March 19, 2024
·
4 min read
Press Releases
Alto Neuroscience Highlights Peer-Reviewed Publication of PAX-D Study in The Lancet Psychiatry Demonstrating Robust Clinical Effects of Pramipexole for Patients with Treatment-Resistant Depression
July 1, 2025
·
6 min read
Press Releases
EVQLV Launches Abtique, the First Marketplace for AI-Designed Molecules Validated in Independent Labs
New “click-to-sequence” platform lets researchers buy AI-designed antibody sequences online, using an AI system that learns from real lab results
November 20, 2025
·
1 min read
Pharm Country
PaxMedica Achieves Key Milestone in the Development of PAX-101 And Provides Update on Potential NDA Submission
PaxMedica, Inc. (NASDAQ:PXMD), a biopharmaceutical company focused on advancing treatments for neurological disorders, today announced the completed execution of its three pivotal registration/validation batches of PAX-101, an IV formulation of suramin.
April 11, 2024
·
5 min read
Business
Alimera Appoints Maggie A. Pax to Its Board of Directors
Alimera Sciences, Inc., a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer, announces the addition of Maggie A. Pax to its Board of Directors.
November 8, 2023
·
3 min read
Press Releases
Unchained Labs Cracks the Code on ADC Characterization
January 6, 2026
·
1 min read
Press Releases
Slope and CellCarta Expand Collaboration with Lab Kit Inventory Portal Agreement
February 3, 2026
·
3 min read
Press Releases
LifeCanvas to advance spatial profiling of human tumors with translational cancer lab
February 3, 2026
·
2 min read
Biotech Bay
Novel Research by PAX and Zentrela Suggests Cannabis “Entourage Effect,” Not THC Potency, Responsible for Psychoactive Experience
PAX, a leading global cannabis brand, today announced a collaboration with pioneering Canadian neurotechnology company, Zentrela, leveraging brainwave research to provide consumers with data-driven insight into cannabis effects — ultimately supporting more informed purchasing and consumption decisions.
October 3, 2023
·
3 min read
Press Releases
Multiply Labs Announces New Collaboration to Automate Cell Therapy Manufacturing with Robotics
January 28, 2026
·
2 min read
1 of 5,719
Next
